Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 303 | 321 | 321 | 315 | 344 | 355 | 357 | 374 | 392 | 407 | 414 | 431 |
| Expenses | 217 | 225 | 229 | 229 | 248 | 252 | 256 | 268 | 285 | 291 | 303 | 307 |
| Operating Profit | 85 | 96 | 92 | 86 | 96 | 103 | 101 | 106 | 107 | 116 | 111 | 124 |
| OPM % | 28% | 30% | 29% | 27% | 28% | 29% | 28% | 28% | 27% | 28% | 27% | 29% |
| Other Income | 4 | 5 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 8 | 7 |
| Interest | 8 | 7 | 7 | 7 | 8 | 9 | 9 | 9 | 9 | 8 | 6 | 8 |
| Depreciation | 23 | 23 | 24 | 24 | 24 | 25 | 25 | 26 | 27 | 28 | 29 | 32 |
| Profit before tax | 58 | 71 | 67 | 61 | 67 | 75 | 74 | 76 | 78 | 87 | 84 | 92 |
| Tax % | 26% | 25% | 22% | 25% | 25% | 23% | 26% | 25% | 24% | 25% | 25% | 25% |
| Net Profit | 43 | 53 | 52 | 46 | 51 | 58 | 55 | 57 | 59 | 65 | 63 | 69 |
| EPS in Rs | 39.67 | 48.53 | 47.69 | 41.81 | 46.32 | 52.82 | 49.99 | 52.30 | 53.79 | 59.42 | 57.89 | 63.14 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 465 | 531 | 588 | 628 | 712 | 690 | 905 | 1,020 | 1,220 | 1,371 | 1,586 | 1,644 |
| Expenses | 374 | 406 | 459 | 494 | 540 | 495 | 645 | 746 | 874 | 981 | 1,141 | 1,186 |
| Operating Profit | 92 | 125 | 129 | 135 | 171 | 195 | 261 | 274 | 346 | 390 | 445 | 458 |
| OPM % | 20% | 23% | 22% | 21% | 24% | 28% | 29% | 27% | 28% | 28% | 28% | 28% |
| Other Income | 8 | 6 | 7 | 8 | 10 | 12 | 12 | 14 | 21 | 21 | 26 | 29 |
| Interest | 17 | 15 | 13 | 15 | 18 | 33 | 46 | 43 | 37 | 36 | 36 | 31 |
| Depreciation | 21 | 24 | 34 | 36 | 52 | 68 | 85 | 89 | 92 | 98 | 109 | 115 |
| Profit before tax | 62 | 92 | 89 | 93 | 112 | 106 | 141 | 155 | 238 | 278 | 326 | 341 |
| Tax % | 35% | 35% | 35% | 35% | 15% | 27% | 26% | 25% | 24% | 25% | 25% | |
| Net Profit | 40 | 60 | 58 | 60 | 95 | 78 | 104 | 116 | 180 | 209 | 244 | 256 |
| EPS in Rs | 36.95 | 54.81 | 52.99 | 54.96 | 86.44 | 71.00 | 95.28 | 105.80 | 164.25 | 190.96 | 223.41 | 234.24 |
| Dividend Payout % | 7% | 5% | 6% | 5% | 3% | 4% | 6% | 9% | 6% | 5% | 7% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 13% | 18% | 16% | 15% | ||
| Compounded Profit Growth | 20% | 26% | 28% | 16% | ||
| Stock Price CAGR | 22% | 29% | 32% | -4% | ||
| Return on Equity | 21% | 20% | 21% | 20% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 127 | 165 | 224 | 276 | 332 | 420 | 499 | 598 | 708 | 878 | 1,075 | 1,308 |
| Borrowings | 163 | 158 | 125 | 202 | 378 | 543 | 623 | 550 | 511 | 310 | 415 | 403 |
| Other Liabilities | 85 | 96 | 103 | 116 | 129 | 134 | 148 | 184 | 209 | 240 | 299 | 345 |
| Total Liabilities | 386 | 430 | 464 | 605 | 850 | 1,108 | 1,281 | 1,343 | 1,439 | 1,439 | 1,801 | 2,067 |
| Fixed Assets | 281 | 337 | 354 | 443 | 469 | 643 | 1,033 | 1,085 | 1,088 | 1,118 | 1,283 | 1,474 |
| CWIP | 17 | 10 | 6 | 13 | 227 | 300 | 45 | 5 | 23 | 39 | 154 | 135 |
| Investments | 4 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 85 | 78 | 100 | 149 | 153 | 165 | 203 | 253 | 328 | 282 | 364 | 458 |
| Total Assets | 386 | 430 | 464 | 605 | 850 | 1,108 | 1,281 | 1,343 | 1,439 | 1,439 | 1,801 | 2,067 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 97 | 85 | 99 | 87 | 126 | 166 | 186 | 262 | 263 | 344 | 335 | 362 |
| Cash from Investing Activity | -80 | -113 | -83 | -192 | -352 | -349 | -180 | -292 | -358 | -290 | -593 | -514 |
| Cash from Financing Activity | -43 | -24 | -50 | 60 | 160 | 113 | 38 | -119 | -86 | -243 | 62 | -58 |
| Net Cash Flow | -26 | -53 | -33 | -45 | -66 | -70 | 44 | -149 | -180 | -189 | -197 | -210 |
| Free Cash Flow | 60 | 14 | 63 | -41 | -151 | -102 | 5 | 163 | 136 | 206 | -18 | 111 |
| CFO/OP | 119% | 109% | 99% | 92% | 117% | 115% | 106% | 115% | 110% | 116% | 101% | 100% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 7 | 8 | 8 | 6 | 4 | 7 | 8 | 8 | 5 | 8 | 9 |
| Inventory Days | 25 | 22 | 20 | 23 | 20 | 23 | 19 | 19 | 18 | 17 | 15 | 17 |
| Days Payable | 53 | 47 | 37 | 43 | 47 | 46 | 29 | 20 | 35 | 30 | 27 | 20 |
| Cash Conversion Cycle | -19 | -19 | -9 | -12 | -21 | -19 | -2 | 6 | -9 | -7 | -4 | 6 |
| Working Capital Days | -60 | -56 | -50 | -48 | -55 | -39 | -56 | -49 | -48 | -49 | -57 | -58 |
| ROCE % | 27% | 25% | 31% | 24% | 18% | 15% | 13% | 16% | 17% | 23% | 23% | 23% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 56.43% | 56.44% | 56.47% | 56.50% | 56.51% | 56.55% | 56.55% | 56.55% | 56.52% | 56.53% | 56.53% | 56.53% |
| FIIs | 2.25% | 2.24% | 0.34% | 0.32% | 0.44% | 0.55% | 1.10% | 1.27% | 1.25% | 1.31% | 1.21% | 1.25% |
| DIIs | 2.09% | 2.09% | 4.18% | 4.28% | 4.37% | 4.43% | 4.03% | 4.52% | 4.89% | 4.73% | 4.47% | 4.24% |
| Public | 39.24% | 39.24% | 39.02% | 38.91% | 38.67% | 38.46% | 38.32% | 37.65% | 37.34% | 37.43% | 37.80% | 37.98% |
| No. of Shareholders | 10,730 | 10,338 | 11,918 | 13,147 | 14,800 | 15,951 | 17,086 | 17,650 | 18,681 | 18,644 | 18,864 | 19,362 |
Fundamentals
Market Cap₹ 6,579 Cr.
Current Price₹ 6,014
Stock P/E25.7
Book Value₹ 1,206
ROCE22.6 %
ROE20.5 %
Dividend Yield0.25 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)15%
Compounded Profit Growth (TTM)16%
Standalone figures.
Valuation
Market capRs 6,558 Cr
Enterprise valueRs 6,614 Cr
P/E (TTM)25.59x
Price to book4.97x
Price to sales3.99x
EV / EBITDA13.58x
EV / EBIT17.79x
EV / sales4.02x
Price to cash flow18.13x
Earnings yield3.91%
Dividend yield0.25%
P/E, 3-year average24.13x
P/B, 3-year average4.66x
P/E, 5-year average21.31x
P/B, 5-year average3.93x
Profitability
Operating margin (excl. other income)28.04%
Operating margin (incl. other income)29.68%
EBITDA margin29.62%
Pre-tax margin20.73%
Net profit margin15.59%
Net margin, latest quarter16.02%
ROE20.33%
ROCE22.41%
ROA12.64%
ROE, 3-year average21.28%
ROCE, 3-year average22.75%
ROA, 3-year average12.68%
ROE, 5-year average19.98%
ROCE, 5-year average20.23%
ROA, 5-year average10.86%
ROIC (approx.)20.29%
Tax rate24.94%
Other income / net worth1.97%
Growth
Sales growth (latest year)15.65%
Profit growth (latest year)16.99%
Sales CAGR, 3 years15.85%
Sales CAGR, 5 years18.09%
Profit CAGR, 3 years28.29%
Profit CAGR, 5 years25.77%
Sales growth QoQ4.28%
Profit growth QoQ9.06%
Sales growth YoY (latest quarter)15.35%
Profit growth YoY (latest quarter)20.72%
Per share
EPS (TTM)Rs 234.25
EPS (latest year)Rs 223.41
EPS (latest quarter)Rs 63.14
EPS, 3-year averageRs 192.87
EPS, 5-year averageRs 155.94
Book value per shareRs 1,205.66
Sales per shareRs 1,502.37
Cash flow per shareRs 330.67
Free cash flow per shareRs 101.44
Dividend per share (latest year)Rs 15.00
Dividend per share, 3-year averageRs 11.66
Dividend per share, 5-year averageRs 10.20
Dividends
Dividend payout6.71%
Dividend payout, 3-year average6.01%
Dividend payout, 5-year average6.76%
Efficiency
Asset turnover0.77x
Fixed asset turnover1.08x
Inventory turnover36.82x
Inventory days10 days
Debtor days9 days
Debtors turnover41.64x
Creditor days20 days
Cash conversion cycle6 days
Working capital days-58 days
Leverage
Total debtRs 403 Cr
Cash and bankRs 347 Cr
Net debtRs 56 Cr
Debt to equity0.31x
Net debt / EBITDA0.11x
Interest coverage12.04x
Owners' fund to total sources63.83%
Debt to assets19.49%
Cash flow
Cash from Operating Activity (latest year)Rs 362 Cr
Cash from Investing Activity (latest year)Rs -514 Cr
Cash from Financing Activity (latest year)Rs -58 Cr
Net Cash Flow (latest year)Rs -210 Cr
Free cash flow (latest year)Rs 111 Cr
FCFE (approx.: FCF + change in debt)Rs 98 Cr
Cash from ops / profit, 5 years1.84x
Sales to cash flow4.38x
Statement figures
Net sales (TTM)Rs 1,644 Cr
Net sales (latest year)Rs 1,586 Cr
Sales (latest quarter)Rs 431 Cr
Operating profit excl. other income (latest year)Rs 445 Cr
Operating profit (latest quarter)Rs 124 Cr
Other income (TTM)Rs 29 Cr
EBITDA (TTM)Rs 487 Cr
PBDT (TTM)Rs 456 Cr
Profit before tax (TTM)Rs 341 Cr
Tax (latest year)Rs 81 Cr
Net profit (TTM)Rs 256 Cr
Net profit (latest year)Rs 244 Cr
Net profit (latest quarter)Rs 69 Cr
Depreciation (TTM)Rs 115 Cr
Depreciation (latest quarter)Rs 32 Cr
Interest (TTM)Rs 31 Cr
Cost of goods sold (latest year)Rs 772 Cr
Total expenditure (latest year)Rs 1,141 Cr
Total income (latest year)Rs 1,612 Cr
Share capitalRs 11 Cr
ReservesRs 1,308 Cr
Shareholders' fundsRs 1,319 Cr
Total assetsRs 2,067 Cr
Net blockRs 1,474 Cr
Capital work in progressRs 135 Cr
InvestmentsRs 1 Cr
ReceivablesRs 38 Cr
InventoryRs 21 Cr
Other liabilitiesRs 345 Cr
Shares outstanding (crore)1.09
Ownership
Promoter holding56.53% (-0.02 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 25.6 is at the 82th percentile of its own 2.8-year range
(median 23.4, low 15.3, high 26.9).
P/B 4.97 is at the 82th percentile (median 3.59).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | KOVAI | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.8% | -2.8% | +1.0 pts |
| 1 month | -0.7% | -6.8% | +6.1 pts |
| 3 months | -0.8% | -7.6% | +6.8 pts |
| 6 months | +134.2% | +0.4% | +133.8 pts |
| 1 year | +215.5% | -9.9% | +225.4 pts |
| 2 years | +255.0% | -13.6% | +268.6 pts |
| 3 years | +131.0% | +14.2% | +116.9 pts |
| 5 years | +249.2% | +27.9% | +221.3 pts |
12 mutual fund schemes hold about ₹193 Cr.
Over three months 2 bought more and 5 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| DSP Healthcare Fund | 2.80% | 107 | -2% |
| Sundaram Small Cap Fund | 1.10% | 46 | -5% |
| WOC Special Opp Fund | 0.81% | 16 | -9% |
| WOC Multi Cap Fund | 0.24% | 10 | -11% |
| WOC Pharma and Healthcare Fund | 0.99% | 9 | -7% |
| DynaSIF Equity Ex-Top 100 Long-Short Fund | 1.93% | 3 | +100% |
| WOC ELSS Tax Saver Fund | 0.27% | 1 | -5% |
| Samco Multi Cap Fund | 0.17% | 0 | +100% |
| Bandhan BSE Healthcare Index Fund | 0.17% | 0 | -3% |
| Motilal Oswal BSE 1000 Index Fund | 0.01% | 0 | +1% |
| Quant Value Fund | 0.00% | 0 | -100% |
| Unifi Flexi Cap Fund | 0.00% | 0 | -100% |
Red flags
F-score 7 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹431 Cr +15.2% vs Jun 2025.
Net profit ₹69 Cr +21.1%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Artemis Medicare Services Ltd | 5,818 | 50.4 | 14.5 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-08-19 | Dividend - Rs 15 Per Share | |
| 2023-08-11 | Dividend - Rs 5 Per Share/Special Dividend - Rs 5 Per Share | |
| 2023-08-11 | Annual General Meeting | |
| 2022-08-25 | Annual General Meeting/Dividend - Rs 3 Per Share/Special Dividend Rs 3 Per Share | |
| 2021-09-02 | Annual General Meeting/Dividend - Rs 3 Per Share | |
| 2014-08-25 | Annual General Meeting / Final Dividend - Rs 1.50/- Per Share | |
| 2013-07-11 | Annual General Meeting And Dividend Rs.1.50 Per Share | |
| 2012-06-28 | Annual General Meeting / Div Of Rs. 1.25/- Per Share | |
| 2011-08-11 | Annual General Meeting And Dividend Rs 1.25 Per Share | |
| 2010-07-29 | Annual General Meeting And Dividend Rs.1.25 Per Share |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Kovai Medical Center & Hospital Ltd?
Kovai Medical Center & Hospital Ltd (KOVAI) has a market capitalisation of Rs 6,579 Cr. at the 2026-10-01 close.
What is the P/E ratio of Kovai Medical Center & Hospital Ltd?
Kovai Medical Center & Hospital Ltd trades at a P/E of 25.7 on trailing twelve-month profit, at the 2026-10-01 close.
What were Kovai Medical Center & Hospital Ltd's latest quarterly results?
In the Jun 2026 quarter, Kovai Medical Center & Hospital Ltd sales was Rs 431 Cr (+15.2% vs Jun 2025) and net profit was Rs 69 Cr.
What is the 52-week high and low of Kovai Medical Center & Hospital Ltd?
The 52-week high is Rs 6,444.00 and the 52-week low is Rs 5,275.50.